NZD/USD fills the week-start gap above 0.6900 on upbeat New Zealand Q3 Retail Sales

  • NZD/USD takes the bids after a big positive beat of the NZ Retail Sales.
  • New Zealand data crossed downbeat forecasts amid recovery from coronavirus-led activity restrictions in Q3.
  • Trading sentiment struggles amid fears of a brake to the Fed’s emergency lending programs, covid resurgence.
  • November month PMIs become the key data, risk catalysts shouldn’t be ignored.

NZD/USD rises to 0.6930 during the initial hour of Monday’s Asian trading. The pair began the week on a back-foot while printing a 20-pips gap-down opening to 0.6918. However, the recently flashed New Zealand Retail Sales for the third quarter (Q3) helped the quote to fill the difference from Friday’s closing near 0.6940.

NZ Retail Sales favors RBNZ’s bullish bias…

New Zealand (NZ) Retail Sales for Q3 overcome the previous quarter’s -14.6% QoQ contraction while rising 28.00%. Further, the Core Retail Sales also jumped above -13.7% previous declines to 24.1% QoQ.

Read: New Zealand’s Retail Sales unexpectedly jumped 8.3% in Q3, NZD/USD bounces

The data offered additional positives to the Reserve Bank of New Zealand (RBNZ) policymakers who have been bullish off-late. Although the RBNZ Governor Adrian Orr cited fears of the global coronavirus (COVID-19) resurgence in his latest speech, the central banker turned down the negative rates while praising the Pacific economy for its performance to tame the pandemic at home.

Elsewhere, global risks remain depressed amid fears that the US Federal Reserve will have a limited capacity to battle the virus. US Treasury Secretary Steve Mnuchin recently recalled the $500 billion of funds with the Fed while indicating the term expiry. This triggered fears that the US central bank will be left with fewer resources and pushed Fed Chair Jerome Powell and company to resist the demands.

Additionally, the COVID-19 outbreak is worsening in the US and Europe. Wall Street Journal cites a reduction in the daily cases from the record high numbers but a sustained surge in the hospitalization keeps the deadly virus as the major fears for Americans.

Virus vaccines and treatments are battling the bears. Recently Regeneron’s Antibody treatment got a go from the US Food and Drug Administration (FDA) for emergency use while Pfizer is up for the UK’s greenback by this weekend, as per the Telegraph. Also on the positive side could be the US President-elect Joe Biden’s firming up the grip on the American leadership.

Even so, global traders will pay close attention to the November month’s activity numbers for fresh impulse while also keeping an eye over the risk catalysts mentioned above.

Technical analysis

Unless declining back below the 0.6800 mark, comprising multiple highs flashed during the mid-2019 and September 2020, bulls are likely to keep the reins. In doing so, the 0.7000 psychological magnet can become their immediate target. However, a downside break of 10-day SMA, currently near 0.6880 can trigger intraday selling.

Additional important levels

Today last price 0.693
Today Daily Change -9 pips
Today Daily Change % -0.13%
Today daily open 0.6939
Daily SMA20 0.6781
Daily SMA50 0.6693
Daily SMA100 0.6656
Daily SMA200 0.6418
Previous Daily High 0.6952
Previous Daily Low 0.6904
Previous Weekly High 0.6952
Previous Weekly Low 0.6841
Previous Monthly High 0.6726
Previous Monthly Low 0.6546
Daily Fibonacci 38.2% 0.6934
Daily Fibonacci 61.8% 0.6923
Daily Pivot Point S1 0.6911
Daily Pivot Point S2 0.6884
Daily Pivot Point S3 0.6863
Daily Pivot Point R1 0.696
Daily Pivot Point R2 0.698
Daily Pivot Point R3 0.7008



Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Feed news

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD advances after US PCE inflation

EUR/USD pressures weekly highs as US core PCE inflation jumped to 3.4% YoY in May, as expected. High yielding assets accelerate their advances to the detriment of the greenback, as government bond yields hold steady.


GBP/USD battles with 1.3900, still affected by BOE’s decision

GBP/USD remains depressed around 1.3900, pressured by the dovish BOE's surprise offsetting the renewed weakness in the US dollar. Worsening market mood amid Delta covid strain concerns weigh on the pound


XAU/USD rises towards key $1794 resistance ahead of US PCE inflation

Gold is picking up the bid tone in European trading, taking advantage of the retreat in the US Treasury yield and the dollar across the curve. 

Gold News

SafeMoon Price Prediction: SAFEMOON ponders 25% advance

SafeMoon price has underperformed relative to top altcoins but is preparing for a move higher. A retest of the range low at $0.00000257 seems likely before SAFEMOON catapults.

Read more

US PCE inflation preview: Data likely to reaffirm FOMC's hawkish tilt

The US Bureau of Economic Analysis will release the PCE inflation report on Friday, June 25. Markets expect the Core PCE Price Index, the Federal Reserve’s preferred gauge of inflation, to rise to 3.4% on a yearly basis in May from 3.1% in April.

Read more